Menu
ncarol.com
  • Home
  • Business
  • Financial
  • Yacht Buyer
  • Stocks
  • Finance
  • Banking
  • Nyse
  • Loans
ncarol.com

New Study Reveals Alarming Cardiac Risks Associated with Electroshock Treatment
ncarol.com/10274175

Trending...
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
  • Still Using Ice? FrostSkin Reinvents Hydration
  • High-Margin Energy & Digital Infrastructure Platform Created after Merger with Established BlockFuel Energy, Innovation Beverage Group (NAS DAQ: IBG)
Study Reveals Cardiac Risks Associated with ECT
The mental health industry watchdog, CCHR, says informed consent is breached every time patients are not warned of the brain damage, long-term memory loss, and cardiac risks, including death, associated with electroshock, per the study.

LOS ANGELES - ncarol.com -- A new study has determined that as many as 1 in 15 people who receive electroshock treatment face life-threatening heart problems, which can lead to death. John Read, Ph.D., a Professor of Psychology at the University College of London critiqued studies of electroconvulsive therapy (ECT) and cited a 2019 review that he says misrepresented data and falsely asserted that ECT is safe. In reality, cardiac events are the leading cause of death for those subjected to shock treatment.[1] The Citizens Commission on Human Rights International, a mental health industry watchdog, says this critical information must be transparently communicated to patients recommended for ECT, including the risks of permanent brain damage and memory loss. According to Dr. Read's study, "the ethical principle of informed consent is being routinely breached by ECT psychiatrists."

Jan Eastgate, President of CCHR International, says that for decades there has been a cover-up of the seriousness of the effects of ECT, which sends up to 460 volts of electricity through the brain, causing a grand mal seizure. "Electroshock has no place in mental health treatment and should be banned," she said, adding, "Given without a patient's consent is internationally recognized as constituting torture."

According to U.S. expert, Ken Castleman, a biomedical engineer, "ECT stimulates the sympathetic nervous system, which controls many aspects of cardiovascular function. The powerful electrical discharge causes a spike in blood pressure. The intense stress that the ECT-induced seizure places on the heart increases the risk of adverse cardiovascular events, especially in patients who have pre-existing cardiac conditions."

More on ncarol.com
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • DASH Carolina RDU Sets the Pace in 2025 with Record-Breaking Sales and Team Excellence
  • Wespor Business Launches AI Voice and Chat Agents to Help Triangle Small Businesses Capture Missed Leads
  • America's Boating Club Ushers in New Board at Change of Watch
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP

Dr. Read reports, "The obligation to ensure informed consent is a core ethical principle of all health and mental health professionals." Yet, "Various official reports, most psychiatric textbooks, and many patient information leaflets have claimed, for decades, that the risk of death from ECT is so rare as to be inconsequential," including an American Psychiatric Association (APA) ECT Task Force Report on ECT. "It should be noted that six of the eight task force members were directors of ECT services." The group included three members who were financially involved with companies manufacturing ECT machines, Dr. Read wrote.

Citing the 2023 joint guidance by the World Health Organization/United Nations, Dr. Read continued: "People being offered ECT should be made aware of all its risks and potential short- and long-term harmful effects, such as memory loss and brain damage. ECT is not recommended for children, and this should be prohibited through legislation."

The study further discusses the death rate:
  • Of 8,148 ECT recipients in Texas, seven died within 2 days of their last ECT. Even excluding the two that the researchers believed were "unlikely to have been related to ECT," this is a "rate of 1 per 1,630 people. If one includes the additional eight that died, from 'cardiac events' in the following 12 days, the rate is 1 per 627."
  • A 2019 review of 43 ECT studies with mortality data, including more than 75,000 patients, calculated, "All-cause mortality was 0.42 deaths per 1,000 patients." This is 1 per 2,380 people, more than four times greater than the official position of the APA of 1 per 10,000.
  • A 2023 Swedish register-based study was comprehensive in finding that of 20,225 ECT patients, 123 (0.61%) died of "medical causes" within 30 days of their last ECT—one death per 164 people. At one per 413 patients, the 49 cardiac-related deaths represented the most common medical cause of post-ECT death (40%). This was surpassed only by the 93 suicides (1 per 217).  In total, 15 of the 23 patients who died within 24 hours of ECT were cardiovascular deaths.
As Dr. Read points out, in 2001, the APA acknowledged that "evidence has shown that ECT can result in persistent or permanent memory loss." In 2018, an ECT device manufacturer included "permanent brain damage" in its list of risks, yet this information was not being forwarded to patients.

More on ncarol.com
  • $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • PRÝNCESS Builds Anticipation With "My Nerves" — A Girls-Girl Anthem
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • From Sleepless Nights to Sold-Out Drops: Catch Phrase Poet's First Year Redefining Motivational Urban Apparel

In the U.S., adolescents and even children five years old and younger have been electroshocked. Dr. Read found "rates of memory deficits in more than two-thirds of child and adolescent ECT patients" that were passed off as "acceptable" and misrepresented as a "high level of safety." Dr. Read wrote to the journal stating: "The use of sufficient electricity, once, on a developing brain, in order to cause a seizure in that young brain, is a very serious matter. To do so five or six times in a few weeks is almost bound to cause brain damage in a significant number of recipients. The average age of these youngsters was just 15.5 years. Most (62 %) were girls. When even the psychiatrists themselves acknowledge that 69 % have impaired memories as a result, this does not indicate a treatment with a 'high' degree of safety."

The main cardiac events Dr. Read found are myocardial infarction (heart attack), life-threatening arrhythmia (irregular heartbeat), acute pulmonary edema (fluid on the lungs), pulmonary embolism (blood clots), acute heart failure, and cardiac arrest.

In light of these grave risks, CCHR welcomes the recent news that electroshock is nearly on the brink of disappearing due to public awareness campaigns, including CCHR's documentary, Electroshock: Therapy or Torture. "It's an incredible story that goes back decades," says Harold Sackeim, a psychologist and major proponent of ECT, who is worried that exposure of ECT could be "successful at killing an industry."

Ms. Eastgate responds, "It is far better that the multi-billion-dollar electroshock industry be killed off rather than its patients. Their safety must be the priority. The current study and many others reflect the ongoing concerns that ECT should be banned."

About CCHR: Established in 1969 by the Church of Scientology and professor of psychiatry, Dr. Thomas Szasz, CCHR has secured state bans of ECT use on minors. It also had Deep Sleep Treatment (DST), which includes ECT, banned in Australia, which last year the WHO said should be prohibited worldwide.

Source:

[1] Read, J. 2024. Major adverse cardiac events and mortality associated with electroconvulsive therapy: Correcting and updating a 2019 meta-analysis. Ethical Human Psychology and Psychiatry, repository.uel.ac.uk/item/8xyx0

Contact
Citizens Commission on Human Rights
***@cchr.org


Source: Citizens Commission on Human Rights

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Boonuspart.ee Acquires Kasiino-boonus.ee to Strengthen Its Position in the Estonian iGaming Market
  • Vines of Napa Launches Partnership Program to Bolster Local Tourism and Economic Growth
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
  • Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season
  • Still Using Ice? FrostSkin Reinvents Hydration
  • Patron Saints Of Music Names Allie Moskovits Head Of Sync & Business Development
  • Dave Aronberg Named 2026 John C. Randolph Award Recipient by Palm Beach Fellowship of Christians & Jews
  • General Relativity Challenged by New Tension Discovered in Dark Siren Cosmology
  • Unseasonable Warmth Triggers Early Pest Season Along I-5 Corridor
  • Bug Busters Expands Service Footprint With New Carrollton, Georgia Branch
  • Why KULR Could Be a Quiet Enabler of Space-Based Solar Power (SBSP) Over The Long Term: KULR Technology Group, Inc. (NY SE American: KULR)
  • Why Finland Had No Choice But to Legalize Online Gambling
  • High-Margin Energy & Digital Infrastructure Platform Created after Merger with Established BlockFuel Energy, Innovation Beverage Group (NAS DAQ: IBG)
  • iFLO Pro Launches Its Groundbreaking iFLO Pro Mini At The 2026 AHR Expo In Las Vegas
  • TL International Group Becomes First Global Operator to Fully Migrate to Pulsant's Dedicated Car Rental Cloud
  • Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways
  • Deep Learning Robotics (DLRob) Announces Pre-Launch of Zero-Teach and Teach-by-Demonstration Technology for Kitting Applications
  • The Quasar Dipole Phenomenon is likely just a complex systematics artifact
  • The Rise of Comprehensive Home Water Treatment Systems
  • Yazaki Innovations to Introduce First-Ever Prefabricated Home Wiring System to U.S. Residential Market in 2026
_catLbl0 _catLbl1

Popular on ncarol.com

  • Crossroads4Hope Welcomes New Trustees to Board of Directors as Organization Enters 25th Year of Caring - 118
  • Desert Mountain Club Earns Prestigious Blue Zones Approved™ Triple Designation, a New Standard for Well-Being in a Luxury Lifestyle Community
  • $80 Million Revenue Backlog for AI Cybersecurity Company Building the Future of Integrated Cybersecurity and Public Safety: $CYCU
  • Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
  • Impact Futures Group expands through acquisition of specialist healthcare sector training provider Caring for Care
  • New Medium Article Explores Why Emotional Conversations Fail and What Most People Don't Understand About Connection
  • $10 Price Target in Think Equity Report Supported by Inventory Financing Floorplan Boot to $60 Million for 2026 Sales Growth in Pre-Owned Boats: $OTH
  • Powering the AI, Defense and Aerospace Future with Energy Infrastructure and Digital Asset Strength: KULR Technology Group, Inc. $KULR
  • Does EMDR Really Work? New Article Explores How Trauma Gets Stuck in the Brain and How Healing Begins
  • UK Financial Ltd Advances Compliance Strategy With January 30th CATEX Exchange Listing Of Maya Preferred PRA Preferred Class Regulated Security Token

Similar on ncarol.com

  • Florida Keys Visitors Can Save 15 Percent With KeysCaribbean's Advanced Booking Discount
  • Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
  • Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
  • FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
  • CCHR: Decades of Warnings, Persistent Inaction; Studies Raise New Alarms on Psychiatric Drug Safety
  • Arbutus Medical Raises C$9.3M to Accelerate Growth of Surgical Workflow Solutions Outside the OR
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Families Gain Clarity: Postmortem Pathology Expands Private Autopsy Services in St. Louis
  • Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
  • Hubble Tension Solved? Study finds evidence of an 'Invisible Bias' in How We Measure the Universe
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute